Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Cancer Type/Condition:  Esophageal cancer
Near ZIP Code:  within 100 miles of 20910
Results 1-12 of 12 for your search:
Start Over
Phase I/II Study of PDR001 in Patients With Advanced Malignancies
Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: CPDR001X2101, NCI-2015-00577, 2014-003929-17, NCT02404441
Tumor Infiltrating Lymphocytes and Aldesleukin after Chemotherapy and Pembrolizumab in Treating Patients with Metastatic Cancers
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: 10-C-0166, NCI-2013-01461, 100166, 306343, P09567, NCT01174121
Biomarkers in Predicting Response to Docetaxel, Cisplatin, and Fluorouracil in Patients With Metastatic Esophagus, Gastroesophageal Junction, or Stomach Cancer
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 to 80
Trial IDs: J1248/ NA_00073720, NCI-2013-00058, J1248, NCT01715233
Veliparib, Paclitaxel, and Carboplatin in Treating Patients with Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery and Liver or Kidney Dysfunction
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: UPCI 10-115, NCI-2011-02500, CDR0000700997, 8808, NCT01366144
Ganetespib and Ziv-Aflibercept in Treating Patients with Refractory or Metastatic Gastrointestinal Cancer, Non-small Cell Lung Cancer, Urothelial Cancer, or Sarcoma
Phase: Phase I
Type: Biomarker/Laboratory analysis, Diagnostic, Treatment
Age: 18 and over
Trial IDs: 14-C-0150, NCI-2014-00626, 09-25-0099, 141525, P141525, 9605, NCT02192541
Alisertib and Combination Chemotherapy in Treating Patients with Gastrointestinal Tumors
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: VICC GI1536, NCI-2014-02475, 9824, NCT02319018
Collection and Analysis of Stored Human Samples, Specimens, or Data from Patients on Terminated Protocols
Phase: No phase specified
Type: Biomarker/Laboratory analysis
Age: 18 and over
Trial IDs: 08-C-N013, NCI-2015-01186, 04-C-0142, 08CN103, P07268, NCI-08-C-N013, NCT00904514
Blood and Tumor Tissue Samples Collected from Patients with Gastrointestinal Cancer
Phase: No phase specified
Type: Biomarker/Laboratory analysis
Age: 18 and over
Trial IDs: 11-C-0112, NCI-2015-01225, 311713, P10747, NCT01313442
Collection of Tissue Samples in Identifying Novel Therapeutic Targets in Patients with Solid Tumors Undergoing Surgery or Biopsy
Phase: No phase specified
Type: Natural history/Epidemiology, Tissue collection/Repository
Age: 16 and over
Trial IDs: 12-C-0175, NCI-2015-01248, 320831, P121006, NCT01658917
Genetic Testing in Samples from Patients with Thoracic Malignancies and Determining Patient Eligibility to Participate in Clinical Trials
Phase: No phase specified
Type: Biomarker/Laboratory analysis
Age: 18 and over
Trial IDs: 06-C-0014, NCI-2013-02054, 060014, P6650, NCT00242723
Natural History Study of Cancer Susceptibility in Patients with Fanconi Anemia, Inherited Bone Marrow Failure Syndromes, and Family Members
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Natural history/Epidemiology
Age: Not specified
Trial IDs: 02-C-0052, NCI-2013-02026, CGB 7130, NCT00056121, NCT00027274
Molecular Profile-Directed Chemotherapy in Treating Patients with Metastatic HER2 Negative Esophagogastric Cancer
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 2013-0973, NCI-2014-02639, NCT02358863
Start Over